The global market for Cyclizine was estimated to be worth US$ 1375 million in 2023 and is forecast to a readjusted size of US$ 1916.1 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030

Cyclizine - Market

Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo. It may also be used for nausea after general anaesthesia or that which developed from opioid use.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclizine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cyclizine by region & country, by Type, and by Application.

The Cyclizine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclizine.

Market Segmentation

Scope of Cyclizine - Market Report

Report Metric	Details
Report Name	Cyclizine - Market
Forecasted market size in 2030	US$ 1916.1 million
CAGR	4.9%
Forecasted years	2024 - 2030
Segment by Type:	Oral Injection
Segment by Application	Migraine Motion Sickness
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amoun Pharmaceutical, Glaxosmithkline, Pharmascript Limited, Advanz Pharma, Teva, P and D Pharmaceuticals, Wabosan Arzneimittel, Aspen Pharmacare, Amco, Aft Pharmaceuticals, Be-Tabs Pharmaceuticals, Wockhardt UK
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cyclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cyclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cyclizine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Cyclizine - Market size in 2030?

Ans: The Cyclizine - Market size in 2030 will be US$ 1916.1 million.

Who are the main players in the Cyclizine - Market report?

Ans: The main players in the Cyclizine - Market are Amoun Pharmaceutical, Glaxosmithkline, Pharmascript Limited, Advanz Pharma, Teva, P and D Pharmaceuticals, Wabosan Arzneimittel, Aspen Pharmacare, Amco, Aft Pharmaceuticals, Be-Tabs Pharmaceuticals, Wockhardt UK

What are the Application segmentation covered in the Cyclizine - Market report?

Ans: The Applications covered in the Cyclizine - Market report are Migraine, Motion Sickness

What are the Type segmentation covered in the Cyclizine - Market report?

Ans: The Types covered in the Cyclizine - Market report are Oral, Injection

1 Market Overview

1.1 Cyclizine Product Introduction

1.2 Global Cyclizine Market Size Forecast

1.2.1 Global Cyclizine Sales Value (2019-2030)

1.2.2 Global Cyclizine Sales Volume (2019-2030)

1.2.3 Global Cyclizine Sales Price (2019-2030)

1.3 Cyclizine Market Trends & Drivers

1.3.1 Cyclizine Industry Trends

1.3.2 Cyclizine Market Drivers & Opportunity

1.3.3 Cyclizine Market Challenges

1.3.4 Cyclizine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Cyclizine Players Revenue Ranking (2023)

2.2 Global Cyclizine Revenue by Company (2019-2024)

2.3 Global Cyclizine Players Sales Volume Ranking (2023)

2.4 Global Cyclizine Sales Volume by Company Players (2019-2024)

2.5 Global Cyclizine Average Price by Company (2019-2024)

2.6 Key Manufacturers Cyclizine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Cyclizine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Cyclizine

2.9 Cyclizine Market Competitive Analysis

2.9.1 Cyclizine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Cyclizine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclizine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oral

3.1.2 Injection

3.2 Global Cyclizine Sales Value by Type

3.2.1 Global Cyclizine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Cyclizine Sales Value, by Type (2019-2030)

3.2.3 Global Cyclizine Sales Value, by Type (%) (2019-2030)

3.3 Global Cyclizine Sales Volume by Type

3.3.1 Global Cyclizine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Cyclizine Sales Volume, by Type (2019-2030)

3.3.3 Global Cyclizine Sales Volume, by Type (%) (2019-2030)

3.4 Global Cyclizine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Migraine

4.1.2 Motion Sickness

4.2 Global Cyclizine Sales Value by Application

4.2.1 Global Cyclizine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Cyclizine Sales Value, by Application (2019-2030)

4.2.3 Global Cyclizine Sales Value, by Application (%) (2019-2030)

4.3 Global Cyclizine Sales Volume by Application

4.3.1 Global Cyclizine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Cyclizine Sales Volume, by Application (2019-2030)

4.3.3 Global Cyclizine Sales Volume, by Application (%) (2019-2030)

4.4 Global Cyclizine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Cyclizine Sales Value by Region

5.1.1 Global Cyclizine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Cyclizine Sales Value by Region (2019-2024)

5.1.3 Global Cyclizine Sales Value by Region (2025-2030)

5.1.4 Global Cyclizine Sales Value by Region (%), (2019-2030)

5.2 Global Cyclizine Sales Volume by Region

5.2.1 Global Cyclizine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Cyclizine Sales Volume by Region (2019-2024)

5.2.3 Global Cyclizine Sales Volume by Region (2025-2030)

5.2.4 Global Cyclizine Sales Volume by Region (%), (2019-2030)

5.3 Global Cyclizine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Cyclizine Sales Value, 2019-2030

5.4.2 North America Cyclizine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Cyclizine Sales Value, 2019-2030

5.5.2 Europe Cyclizine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Cyclizine Sales Value, 2019-2030

5.6.2 Asia Pacific Cyclizine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Cyclizine Sales Value, 2019-2030

5.7.2 South America Cyclizine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Cyclizine Sales Value, 2019-2030

5.8.2 Middle East & Africa Cyclizine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Cyclizine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Cyclizine Sales Value

6.2.1 Key Countries/Regions Cyclizine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Cyclizine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Cyclizine Sales Value, 2019-2030

6.3.2 United States Cyclizine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Cyclizine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Cyclizine Sales Value, 2019-2030

6.4.2 Europe Cyclizine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Cyclizine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Cyclizine Sales Value, 2019-2030

6.5.2 China Cyclizine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Cyclizine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Cyclizine Sales Value, 2019-2030

6.6.2 Japan Cyclizine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Cyclizine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Cyclizine Sales Value, 2019-2030

6.7.2 South Korea Cyclizine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Cyclizine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Cyclizine Sales Value, 2019-2030

6.8.2 Southeast Asia Cyclizine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Cyclizine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Cyclizine Sales Value, 2019-2030

6.9.2 India Cyclizine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Cyclizine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Amoun Pharmaceutical

7.1.1 Amoun Pharmaceutical Company Information

7.1.2 Amoun Pharmaceutical Introduction and Business Overview

7.1.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Amoun Pharmaceutical Cyclizine Product Offerings

7.1.5 Amoun Pharmaceutical Recent Development

7.2 Glaxosmithkline

7.2.1 Glaxosmithkline Company Information

7.2.2 Glaxosmithkline Introduction and Business Overview

7.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Glaxosmithkline Cyclizine Product Offerings

7.2.5 Glaxosmithkline Recent Development

7.3 Pharmascript Limited

7.3.1 Pharmascript Limited Company Information

7.3.2 Pharmascript Limited Introduction and Business Overview

7.3.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pharmascript Limited Cyclizine Product Offerings

7.3.5 Pharmascript Limited Recent Development

7.4 Advanz Pharma

7.4.1 Advanz Pharma Company Information

7.4.2 Advanz Pharma Introduction and Business Overview

7.4.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Advanz Pharma Cyclizine Product Offerings

7.4.5 Advanz Pharma Recent Development

7.5 Teva

7.5.1 Teva Company Information

7.5.2 Teva Introduction and Business Overview

7.5.3 Teva Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Teva Cyclizine Product Offerings

7.5.5 Teva Recent Development

7.6 P and D Pharmaceuticals

7.6.1 P and D Pharmaceuticals Company Information

7.6.2 P and D Pharmaceuticals Introduction and Business Overview

7.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 P and D Pharmaceuticals Cyclizine Product Offerings

7.6.5 P and D Pharmaceuticals Recent Development

7.7 Wabosan Arzneimittel

7.7.1 Wabosan Arzneimittel Company Information

7.7.2 Wabosan Arzneimittel Introduction and Business Overview

7.7.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Wabosan Arzneimittel Cyclizine Product Offerings

7.7.5 Wabosan Arzneimittel Recent Development

7.8 Aspen Pharmacare

7.8.1 Aspen Pharmacare Company Information

7.8.2 Aspen Pharmacare Introduction and Business Overview

7.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Aspen Pharmacare Cyclizine Product Offerings

7.8.5 Aspen Pharmacare Recent Development

7.9 Amco

7.9.1 Amco Company Information

7.9.2 Amco Introduction and Business Overview

7.9.3 Amco Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Amco Cyclizine Product Offerings

7.9.5 Amco Recent Development

7.10 Aft Pharmaceuticals

7.10.1 Aft Pharmaceuticals Company Information

7.10.2 Aft Pharmaceuticals Introduction and Business Overview

7.10.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Aft Pharmaceuticals Cyclizine Product Offerings

7.10.5 Aft Pharmaceuticals Recent Development

7.11 Be-Tabs Pharmaceuticals

7.11.1 Be-Tabs Pharmaceuticals Company Information

7.11.2 Be-Tabs Pharmaceuticals Introduction and Business Overview

7.11.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Be-Tabs Pharmaceuticals Cyclizine Product Offerings

7.11.5 Be-Tabs Pharmaceuticals Recent Development

7.12 Wockhardt UK

7.12.1 Wockhardt UK Company Information

7.12.2 Wockhardt UK Introduction and Business Overview

7.12.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Wockhardt UK Cyclizine Product Offerings

7.12.5 Wockhardt UK Recent Development

8 Industry Chain Analysis

8.1 Cyclizine Industrial Chain

8.2 Cyclizine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Cyclizine Sales Model

8.5.2 Sales Channel

8.5.3 Cyclizine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

P and D Pharmaceuticals

Be-Tabs Pharmaceuticals

Wockhardt UK

List of Tables

Table 1. Cyclizine Market Trends

Table 2. Cyclizine Market Drivers & Opportunity

Table 3. Cyclizine Market Challenges

Table 4. Cyclizine Market Restraints

Table 5. Global Cyclizine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Cyclizine Revenue Market Share by Company (2019-2024)

Table 7. Global Cyclizine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Cyclizine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Cyclizine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Cyclizine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Cyclizine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Cyclizine

Table 13. Global Cyclizine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclizine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Cyclizine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Cyclizine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Cyclizine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Cyclizine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Cyclizine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Cyclizine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Cyclizine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Cyclizine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Cyclizine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Cyclizine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Cyclizine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Cyclizine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Cyclizine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Cyclizine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Cyclizine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Cyclizine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Cyclizine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Cyclizine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Cyclizine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Cyclizine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Cyclizine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Cyclizine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Cyclizine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Cyclizine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Cyclizine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Cyclizine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Cyclizine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Cyclizine Sales Value by Region (2019-2024) & (%)

Table 44. Global Cyclizine Sales Value by Region (2025-2030) & (%)

Table 45. Global Cyclizine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Cyclizine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Cyclizine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Cyclizine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Cyclizine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Cyclizine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Cyclizine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Cyclizine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Cyclizine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Cyclizine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Cyclizine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Cyclizine Sales Volume, (2025-2030) & (K Units)

Table 57. Amoun Pharmaceutical Company Information

Table 58. Amoun Pharmaceutical Introduction and Business Overview

Table 59. Amoun Pharmaceutical Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Amoun Pharmaceutical Cyclizine Product Offerings

Table 61. Amoun Pharmaceutical Recent Development

Table 62. Glaxosmithkline Company Information

Table 63. Glaxosmithkline Introduction and Business Overview

Table 64. Glaxosmithkline Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Glaxosmithkline Cyclizine Product Offerings

Table 66. Glaxosmithkline Recent Development

Table 67. Pharmascript Limited Company Information

Table 68. Pharmascript Limited Introduction and Business Overview

Table 69. Pharmascript Limited Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Pharmascript Limited Cyclizine Product Offerings

Table 71. Pharmascript Limited Recent Development

Table 72. Advanz Pharma Company Information

Table 73. Advanz Pharma Introduction and Business Overview

Table 74. Advanz Pharma Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Advanz Pharma Cyclizine Product Offerings

Table 76. Advanz Pharma Recent Development

Table 77. Teva Company Information

Table 78. Teva Introduction and Business Overview

Table 79. Teva Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Teva Cyclizine Product Offerings

Table 81. Teva Recent Development

Table 82. P and D Pharmaceuticals Company Information

Table 83. P and D Pharmaceuticals Introduction and Business Overview

Table 84. P and D Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. P and D Pharmaceuticals Cyclizine Product Offerings

Table 86. P and D Pharmaceuticals Recent Development

Table 87. Wabosan Arzneimittel Company Information

Table 88. Wabosan Arzneimittel Introduction and Business Overview

Table 89. Wabosan Arzneimittel Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Wabosan Arzneimittel Cyclizine Product Offerings

Table 91. Wabosan Arzneimittel Recent Development

Table 92. Aspen Pharmacare Company Information

Table 93. Aspen Pharmacare Introduction and Business Overview

Table 94. Aspen Pharmacare Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Aspen Pharmacare Cyclizine Product Offerings

Table 96. Aspen Pharmacare Recent Development

Table 97. Amco Company Information

Table 98. Amco Introduction and Business Overview

Table 99. Amco Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Amco Cyclizine Product Offerings

Table 101. Amco Recent Development

Table 102. Aft Pharmaceuticals Company Information

Table 103. Aft Pharmaceuticals Introduction and Business Overview

Table 104. Aft Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Aft Pharmaceuticals Cyclizine Product Offerings

Table 106. Aft Pharmaceuticals Recent Development

Table 107. Be-Tabs Pharmaceuticals Company Information

Table 108. Be-Tabs Pharmaceuticals Introduction and Business Overview

Table 109. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Be-Tabs Pharmaceuticals Cyclizine Product Offerings

Table 111. Be-Tabs Pharmaceuticals Recent Development

Table 112. Wockhardt UK Company Information

Table 113. Wockhardt UK Introduction and Business Overview

Table 114. Wockhardt UK Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Wockhardt UK Cyclizine Product Offerings

Table 116. Wockhardt UK Recent Development

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Cyclizine Downstream Customers

Table 120. Cyclizine Distributors List

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Cyclizine Product Picture

Figure 2. Global Cyclizine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Cyclizine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Cyclizine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Cyclizine Report Years Considered

Figure 7. Global Cyclizine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Cyclizine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cyclizine Revenue in 2023

Figure 10. Cyclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oral Picture

Figure 12. Injection Picture

Figure 13. Global Cyclizine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Cyclizine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Cyclizine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Cyclizine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Cyclizine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Migraine

Figure 19. Product Picture of Motion Sickness

Figure 20. Global Cyclizine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Cyclizine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Cyclizine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Cyclizine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Cyclizine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Cyclizine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Cyclizine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Cyclizine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Cyclizine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Cyclizine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Cyclizine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Cyclizine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Cyclizine Sales Volume (%), (2019-2030)

Figure 37. United States Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Cyclizine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Cyclizine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Cyclizine Sales Value by Application (%), 2023 VS 2030

Figure 58. Cyclizine Industrial Chain

Figure 59. Cyclizine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions